PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activationJuan Hu, Bin Kong|Journal of Cellular and Molecular Medicine|2021Cited by 19